1. Home
  2. MD vs NVAX Comparison

MD vs NVAX Comparison

Compare MD & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pediatrix Medical Group Inc.

MD

Pediatrix Medical Group Inc.

N/A

Current Price

$31.34

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Logo Novavax Inc.

NVAX

Novavax Inc.

N/A

Current Price

$8.52

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MD
NVAX
Founded
1979
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.1B
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
MD
NVAX
Price
$31.34
$8.52
Analyst Decision
Hold
Buy
Analyst Count
7
9
Target Price
★ $30.08
$14.11
AVG Volume (30 Days)
688.7K
★ 6.1M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
263.03
★ 309.76
EPS
★ 1.43
N/A
Revenue
★ $1,913,849,000.00
$1,123,479,000.00
Revenue This Year
$2.82
N/A
Revenue Next Year
$2.13
N/A
P/E Ratio
$21.94
★ N/A
Revenue Growth
N/A
★ 64.69
52 Week Low
$17.23
$6.20
52 Week High
$33.74
$13.39

Technical Indicators

Market Signals
Indicator
MD
NVAX
Relative Strength Index (RSI) 65.09 37.52
Support Level $25.27 $7.81
Resistance Level $33.74 $10.53
Average True Range (ATR) 1.18 0.76
MACD 0.01 -0.16
Stochastic Oscillator 54.02 5.98

Price Performance

Historical Comparison
MD
NVAX

About MD Pediatrix Medical Group Inc.

Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: